The FDA authorized reformulated versions of the Moderna and Pfizer vaccines that aim to protect against the omicron variant. | via NPR
Vials of the newly reformulated COVID-19 vaccine booster are being readied by Pfizer for distribution now that the Food and Drug Administration has authorized the shots for people 12 and older.
The new shots target both the original strain of the coronavirus and the omicron BA.4/BA.5 subvariants that most people are catching now. This double-barreled vaccine is called a bivalent vaccine. The Moderna COVID-19 vaccine is authorized for use as a single booster dose in people 18 and older. The Pfizer-BioNTech booster is authorized for people 12 years and up. People are eligible for the new boosters two months after completing their initial vaccination or their last booster shot.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
FDA authorizes first revamp of COVID vaccines to target omicronThe new shots from Moderna and Pfizer-BioNTech target both the original strain of the coronavirus and the omicron BA.4/BA.5 subvariants that most people are catching now.
Baca lebih lajut »
FDA Clears Updated COVID Boosters Targeting Newest VariantsFederal regulators on Wednesday authorized its first update to COVID-19 vaccines, booster doses that target today’s most common omicron strain.
Baca lebih lajut »
Pediatric cases rise as Biden administration prepares for rollout of new COVID vaccine boostersExperts predict the FDA could authorize a new COVID-19 booster shot that includes a new formula aimed at targeting the latest omicron variants as early as this week.
Baca lebih lajut »
US clears updated COVID boosters targeting newest variants.S. regulators have authorized updated COVID-19 boosters, the first to directly target today's most common omicron strain.
Baca lebih lajut »
FDA expected to authorize new omicron-specific COVID boosters this weekThe Food and Drug Administration is planning to authorize a new generation of COVID-19 boosters this week that for the first time will target the omicron variant.
Baca lebih lajut »